History of antibiotic discovery and concomitant development of antibiotic resistance. History of antibiotic discovery and concomitant development of antibiotic.

Slides:



Advertisements
Similar presentations
Behaviour Diseases Environment Genetics Infectious diseases.
Advertisements

Chapter Sixteen Science, Technology, and Global Health.
1 Pharmaceutical Challenges for the Semantic Web.
CHAPTER 10 Basic Biopharmaceutics
General Microbiology Nickolas V. Kapp Ph.D. What is a Microbe Smaller than 0.1mm Includes bugs, things, germs, viruses, protozoan, bacteria, animalcules,
Chemical Genetics – Biol503
Biol518 Lecture 2 HTS and Antibiotic Drug Discovery.
The Application of the Scientific Method: Preclinical Trials Copyright PEER.tamu.edu.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
--- History of Molecular Biology
Stages of drug development
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
ANTIBIOTIC RESISTANCE
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Computer aided drug design
Chapter 31 Advances in Molecular Genetics. What is a genome? Genome: is all of an organism’s genetic information. Genomic map of E. coli bacteria.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
Antimicrobial Chemotherapy
Strategies for developing India as a contract research hub Swaminathan Subramaniam Chief Operating Officer Aurigene Discovery Technologies.
Antimicrobial resistance
Dr. Horst Hemmerle Eli Lilly & Company Director Lead Generation Technologies: Responsible for: Compound Collection Enrichment Strategy Screening Strategies.
Pharmacodynamics Department Of Pharmacology. Tolerance: Decreased response to a drug following repeated administration though the dose is constant. Acute.
신기술 접목에 의한 신약개발의 발전전망과 전략 LGCI 생명과학 기술원. Confidential LGCI Life Science R&D 새 시대 – Post Genomic Era Genome count ‘The genomes of various species including.
Pharmaceutical Approaches to Antiviral Drug Discovery
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
Moiz Bakhiet, MD, PhD, Professor and Chairman
Microbial Connections: the rise of antibiotic resistance
Microbial Connections: the rise of antibiotic resistance
What You Can Do to Help Prevent Antibiotic Resistance
What You Can Do to Help Prevent Antibiotic Resistance
Antibiotic Resistance
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Objectives: Understand the nature of antimicrobial chemical compounds that make them useful. Understand the major modes of action by which antimicrobial.
Figure 2 The US Centers for Disease Control and
A new antivirulence approach against pathogenic bacteria
What You Can Do to Help Prevent Antibiotic Resistance
Branko Stefanovic Biomedical Sciences
The Good & the Bad.
Professional Organizations
Drug Design and Drug Discovery
The mechanisms for the origin and proliferation of MDR strains.
Chapter 1 Introduction of Pharmacology [,fɑ:mə'kɔlədʒi] 药理学
Personalized Medicine: Patient-Predictive Panel Power
Shielding of bacterial spores against galactic cosmic radiation by meteorite material. Shielding of bacterial spores against galactic cosmic radiation.
Biochemical function of PRPP
Mechanisms by which microbial cells might develop resistance
Microbial Connections: the rise of antibiotic resistance
Alignments of the complete genome sequences of the B
CTL killing and hepatocyte replacement.
Structural injuries and signs of cell death in fully differentiated Caco-2/TC7 clone cells infected with a Shiga toxin-positive E. coli strain. Structural.
Novel FKBP inhibitors identified by synthetic approaches (A to D) and by screening of databases and compound libraries (E to H), as well as pipecolinic.
Summary of major events in Earth history relating to the appearance of eukaryotic groups and the appearance of O2 in the atmosphere and in marine environments.
Antibacterial Drug Discovery (ADD) at Leeds
Antibiofilm strategies arising from fundamental research.
UV resistance of spores and vegetative cells of B
T4P gene clusters in C. perfringens and C. difficile.
Extreme resistance of D
Prophage genome map of the C. diphtheriae prophage encoding DT
Molecular models for module exchange between phages.
Mechanisms of XRV and ERV transmission.
General scheme of the events triggered by C
Linear relationship between the dose of ionizing radiation and, from top to bottom, the extent of DNA degradation and the delay in DNA synthesis. Linear.
Potential mechanisms for the regulation of host-symbiont biomass in cnidarian-alga symbiosis. 1, expulsion of symbiont cells in either detached whole host.
The selective advantage (relative fitness) of a mutant genome (with its associated cloud) alters the rate of dominance in a population. The selective advantage.
Integron structure and gene capture mechanism.
History of discovered and recommended antimicrobials and evolution of resistance in Neisseria gonorrhoeae, including the emergence of genetic resistance.
General overview of the bioinformatic pipelines for the 16S rRNA gene microbial profiling and shotgun metagenomics. General overview of the bioinformatic.
Simplified representation of several types of genetic modifications that can alter the composition of viral quasispecies. Simplified representation of.
Sequence alignment of colicin lysis proteins.
Presentation transcript:

History of antibiotic discovery and concomitant development of antibiotic resistance. History of antibiotic discovery and concomitant development of antibiotic resistance. The dark ages, the preantibiotic era; primordial, the advent of chemotherapy, via the sulfonamides; golden, the halcyon years when most of the antibiotics used today were discovered; the lean years, the low point of new antibiotic discovery and development; pharmacologic, attempts were made to understand and improve the use of antibiotics by dosing, administration, etc.; biochemical, knowledge of the biochemical actions of antibiotics and resistance mechanisms led to chemical modification studies to avoid resistance; target, mode-of-action and genetic studies led to efforts to design new compounds; genomic/HTS, genome sequencing methodology was used to predict essential targets for incorporation into high-throughput screening assays; disenchantment, with the failure of the enormous investment in genome-based methods, many companies discontinued their discovery programs. Other milestones in this history include the creation of the FDA Office of New Drugs after the thalidomide disaster led to stricter requirements for drug safety, including the use of antibiotics. This slowed the registration of novel compounds. Before antibiotics were discovered, Semmelweis advocated hand washing as a way of avoiding infection; this practice is now strongly recommended as a method to prevent transmission. Julian Davies, and Dorothy Davies Microbiol. Mol. Biol. Rev. 2010; doi:10.1128/MMBR.00016-10